Search results

Order by most recent / most popular / relevance

Results: 1-4 of 4

IP challenges for the personalised medicines industry - gene claims (part 1)

Barker Brettell LLP
-
European Union, United Kingdom, USA
-
May 9 2013

When you go to the doctor you expect to be asked a lot of questions about your symptoms and your lifestyle, as the doctor builds up a clinical

U.K. jumps on “pay-to-delay” bandwagon

Fish & Richardson PC
-
United Kingdom, USA
-
April 24 2013

The U.K. Office of Fair Trading ("OFT") jumped on the "pay-to-delay" bandwagon last week when it issued a "Statement of Objections," indicating a

UK Supreme Court steps into line with Europe, but rejects U.S. approach

McDermott Will & Emery
-
European Union, United Kingdom, USA
-
November 30 2011

The UK’s highest court recently considered the provisions of the European Patent Convention (EPC) centering on the “susceptible of industrial application” requirement in the context of a patent describing a DNA sequence for a new protein, Neutrokine-α, which was a member of a group of similar proteins known as the TNF ligand superfamily

News bytes

Shook Hardy & Bacon LLP
-
United Kingdom, USA
-
April 21 2011

The International Service for the Acquisition of Agri-Biotech Applications SEAsia Center launches a database of biotechgenetically modified crops and traits that have been approved for commercialization and planting, and for import for food and feed

Search results

IP challenges for the personalised medicines industry - gene claims (part 1)

U.K. jumps on “pay-to-delay” bandwagon

UK Supreme Court steps into line with Europe, but rejects U.S. approach

News bytes

Current Search

Suggested Facets

Author

Firm Name

Workarea